Related Experiment Videos
Possible interchromosomal effect in embryos generated by gametes from translocation carriers
L Gianaroli1, M C Magli, A P Ferraretti
1SISMER, Reproductive Medicine Unit, Via Mazzini 12, 40138 Bologna, Italy. sismer@sismer.it
Human Reproduction (Oxford, England)
|November 29, 2002
Summary
Preimplantation genetic diagnosis (PGD) combined with aneuploidy screening can identify abnormal embryos in translocation carriers. This approach helps assess risks for abnormal pregnancies, particularly with Robertsonian translocations.
Area of Science:
- Reproductive genetics
- Human genetics
- Cytogenetics
Background:
- Balanced translocations in carriers significantly influence abnormal pregnancy rates.
- The specific chromosomes involved dictate the risk of pregnancy complications.
Purpose of the Study:
- To evaluate the efficacy of combining preimplantation genetic diagnosis (PGD) with conventional aneuploidy screening for translocation carriers.
- To assess the potential benefits of this combined approach in identifying chromosomally abnormal embryos.
Main Methods:
- Conducted 43 PGD cycles on 28 carriers of Robertsonian and reciprocal translocations.
- Screened 172 embryos for translocation-specific abnormalities and common aneuploidies (chromosomes 13, 16, 18, 21, 22, XY).
- Investigated 40 embryos from reciprocal translocation carriers for common aneuploidies.
Main Results:
- For Robertsonian translocations, 21% of embryos showed translocation-related abnormalities, 31% common aneuploidies, and 36% both.
- In reciprocal translocations, 65% of abnormalities were translocation-related, 6% common aneuploidies, and 16% both.
- A significant proportion of embryos exhibited abnormalities due to both translocation and non-translocation-related chromosomal issues.
Conclusions:
- An interchromosomal effect appears to contribute to aneuploidy in Robertsonian translocations.
- This increased aneuploidy risk in carriers of Robertsonian translocations poses an additional risk for abnormal pregnancies.
- Combined PGD and aneuploidy screening offers valuable insights for translocation carriers.